Acute severe ulcerative colitis: using JAK-STAT inhibitors for improved clinical outcomes
Acute Severe Ulcerative Colitis (ASUC) is a well-known and potentially fatal disease state, characterized by symptoms of systemic toxicity including fever, severe anemia, elevated inflammatory markers, and autonomic instability. The life-threatening nature of this condition requires clinicians to ma...
Saved in:
| Main Authors: | Shruthi Karthikeyan, Chetan Ambastha, Kian Keyashian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Gastroenterology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgstr.2024.1488288/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
by: Raffaele Pellegrino, et al.
Published: (2025-02-01) -
Potential role of upadacitinib in cytomegalovirus colitis recurrence
by: Kaito Tsujinaka, et al.
Published: (2025-04-01) -
State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review
by: Yunseok Choi, et al.
Published: (2025-05-01) -
Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01) -
Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission
by: Nikos Viazis, et al.
Published: (2025-05-01)